Cresco Labs (Cresco Labs) Change In Payables And Accrued Expense : $26.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Change In Payables And Accrued Expense?

Cresco Labs's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was $9.2 Mil. It means Cresco Labs's Accounts Payable & Accrued Expense increased by $9.2 Mil from Dec. 2023 to Mar. 2024 .

Cresco Labs's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $22.5 Mil. It means Cresco Labs's Accounts Payable & Accrued Expense increased by $22.5 Mil from Dec. 2022 to Dec. 2023 .

Cresco Labs Change In Payables And Accrued Expense Historical Data

The historical data trend for Cresco Labs's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Change In Payables And Accrued Expense Chart

Cresco Labs Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

49.13

41.43

23.06

57.48

22.50

Cresco Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															5.68	23.40	26.34	-32.92	9.15

Cresco Labs Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $26.0 Mil.

Cresco Labs Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs (Cresco Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

6CQ:Germany CL:Canada

Address

400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654

Website

https://www.crescolabs.com

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.